These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22136914)

  • 1. Surgical hemostatic agents: assessment of drugs and medical devices.
    Aubourg R; Putzolu J; Bouche S; Galmiche H; Denis C; d'Andon A; Maitrot D; Partensky C
    J Visc Surg; 2011 Dec; 148(6):e405-8. PubMed ID: 22136914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of hemostatic agents used in vascular surgery.
    Allotey JK; King AH; Kumins NH; Wong VL; Harth KC; Cho JS; Kashyap VS
    J Vasc Surg; 2021 Jun; 73(6):2189-2197. PubMed ID: 33253866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a new fibrin sealant with standard topical hemostatic agents.
    Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
    Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
    Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
    Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local hemostatic agent - fluid active hemostatic matrix].
    Zemlyanoy AB
    Khirurgiia (Mosk); 2019; (5):104-115. PubMed ID: 31169828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Hemostatic Patch That Stops Bleeding in Cardiovascular and Peripheral Vascular Procedures.
    Howk K; Fortier J; Poston R
    Ann Vasc Surg; 2016 Feb; 31():186-95. PubMed ID: 26597233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness and versatility of a sealing hemostatic patch (HEMOPATCH) in multiple surgical specialties.
    Lewis KM; Ikeme S; Olubunmi T; Kuntze CE
    Expert Rev Med Devices; 2018 May; 15(5):367-376. PubMed ID: 29658322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery.
    Saif R; Jacob M; Robinson S; Amer A; Kei-Hui D; Sen G; Manas D; White S
    Surg Laparosc Endosc Percutan Tech; 2011 Jun; 21(3):131-41. PubMed ID: 21654294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery.
    Saha SP; Muluk S; Schenk W; Burks SG; Grigorian A; Ploder B; Presch I; Pavlova BG; Hantak E
    Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorbable hemostatic agents.
    Gabay M
    Am J Health Syst Pharm; 2006 Jul; 63(13):1244-53. PubMed ID: 16790576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
    Mathiasen RA; Cruz RM
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic and outcomes consequences of TachoSil®: a systematic review.
    Colombo GL; Bettoni D; Di Matteo S; Grumi C; Molon C; Spinelli D; Mauro G; Tarozzo A; Bruno GM
    Vasc Health Risk Manag; 2014; 10():569-75. PubMed ID: 25246797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fibrin sealants in hemostasis.
    Mankad PS; Codispoti M
    Am J Surg; 2001 Aug; 182(2 Suppl):21S-28S. PubMed ID: 11566473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelatin-thrombin hemostatic matrix in neurosurgical procedures: hemostatic effectiveness and economic value of clinical and surgical procedure-related benefits.
    Esposito F; Cappabianca P; Angileri FF; Cavallo LM; Priola SM; Crimi S; Solari D; Germanò AF; Tomasello F
    J Neurosurg Sci; 2020 Apr; 64(2):158-164. PubMed ID: 27456032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
    Hutchinson RW; Werrlein S; Johns DB; Zhang G; Clymer JW; Kocharian R
    Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel hemostatic devices in thyroid surgery: electrothermal bipolar vessel sealing system and harmonic scalpel.
    Manouras A; Markogiannakis HE; Kekis PB; Lagoudianakis EE; Fleming B
    Expert Rev Med Devices; 2008 Jul; 5(4):447-66. PubMed ID: 18573045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical hemostasis in laparoscopic surgery.
    Vecchio R; Catalano R; Basile F; Spataro C; Caputo M; Intagliata E
    G Chir; 2016; 37(6):266-270. PubMed ID: 28350974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH; Szlam F; Tanaka KA; Sniecienski RM
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
    Rahe-Meyer N; Hanke A; Schmidt DS; Hagl C; Pichlmaier M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study.
    Rousou J; Levitsky S; Gonzalez-Lavin L; Cosgrove D; Magilligan D; Weldon C; Hiebert C; Hess P; Joyce L; Bergsland J
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):194-203. PubMed ID: 2464722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.